Supported by U.S. Food and Drug Administration approval, the new system builds upon work from six years ago by a team of researchers from University Hospitals Cleveland Medical Center and Case Western Reserve University, in collaboration with the Braingate2 consortium.
Limb Reanimation Program Gets Funding
